Switch theme
Sign up to access all valuation multiples
Ilex Medical Ltd is an Israel based company engages in the marketing and distribution of diagnostic products and other medical laboratory information systems. It offers in-vitro diagnostic equipment, reagents, laboratory management software, blood bank diagnostic kits, and diagnostic support services to the healthcare sector in Israel.
1977
n/a
Last FY Revenue $263M
Last FY EBITDA $32.3M
$201M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Ilex Medical achieved revenue of $263M and an EBITDA of $32.3M.
Ilex Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Ilex Medical valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $263M | XXX | XXX | XXX |
| Gross Profit | XXX | $61.8M | XXX | XXX | XXX |
| Gross Margin | XXX | 24% | XXX | XXX | XXX |
| EBITDA | XXX | $32.3M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 12% | XXX | XXX | XXX |
| EBIT | XXX | $18.5M | XXX | XXX | XXX |
| EBIT Margin | XXX | 7% | XXX | XXX | XXX |
| Net Profit | XXX | $11.1M | XXX | XXX | XXX |
| Net Margin | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Ilex Medical's stock price is ILS n/a (or $n/a).
Ilex Medical has current market cap of ILS 830M (or $237M), and EV of ILS 704M (or $201M).
See Ilex Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $201M | $237M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Ilex Medical has market cap of $237M and EV of $201M.
Ilex Medical's trades at 0.8x EV/Revenue multiple, and 6.2x EV/EBITDA.
Equity research analysts estimate Ilex Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ilex Medical's P/E ratio is not available.
See valuation multiples for Ilex Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $237M | XXX | $237M | XXX | XXX | XXX |
| EV (current) | $201M | XXX | $201M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 6.2x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 10.9x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 21.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 14.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialIlex Medical's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Ilex Medical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ilex Medical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Ilex Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 16% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ilex Medical acquired XXX companies to date.
Last acquisition by Ilex Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Ilex Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Ilex Medical founded? | Ilex Medical was founded in 1977. |
| Where is Ilex Medical headquartered? | Ilex Medical is headquartered in Israel. |
| Is Ilex Medical publicy listed? | Yes, Ilex Medical is a public company listed on TAE. |
| What is the stock symbol of Ilex Medical? | Ilex Medical trades under ILX ticker. |
| When did Ilex Medical go public? | Ilex Medical went public in 1995. |
| Who are competitors of Ilex Medical? | Similar companies to Ilex Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Ilex Medical? | Ilex Medical's current market cap is $237M |
| Is Ilex Medical profitable? | Yes, Ilex Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
